Perspectives of Inpatients With Cirrhosis and Caregivers on Using Health Information Technology: Cross-sectional Multicenter Study (Preprint)

BACKGROUND Health information technology (IT) interventions to decrease readmissions for cirrhosis may be limited by patient-associated factors. OBJECTIVE The aim of this study was to determine perspectives regarding adoption versus refusal of health IT interventions among patient-caregiver dyads. METHODS Inpatients with cirrhosis and their caregivers were approached to participate in a randomized health IT intervention trial requiring daily contact with research teams via the Patient Buddy app. This app focuses on ascites, medications, and hepatic encephalopathy over 30 days. Regression analyses for characteristics associated with acceptance were performed. For those who declined, a semistructured interview was performed with themes focused on caregivers, protocol, transport/logistics, technology demands, and privacy. RESULTS A total of 349 patient-caregiver dyads were approached (191 from Virginia Commonwealth University, 56 from Richmond Veterans Affairs Medical Center, and 102 from Mayo Clinic), 87 of which (25%) agreed to participate. On regression, dyads agreeing included a male patient (odds ratio [OR] 2.08, P=.01), gastrointestinal bleeding (OR 2.3, P=.006), or hepatic encephalopathy admission (OR 2.0, P=.01), whereas opioid use (OR 0.46, P=.03) and alcohol-related etiology (OR 0.54, P=.02) were associated with refusal. Race, study site, and other admission reasons did not contribute to refusing participation. Among the 262 dyads who declined randomization, caregiver reluctance (43%), perceived burden (31%), technology-related issues (14%), transportation/logistics (10%), and others (4%), but not privacy, were highlighted as major concerns. CONCLUSIONS Patients with cirrhosis admitted with hepatic encephalopathy and gastrointestinal bleeding without opioid use or alcohol-related etiologies were more likely to participate in a health IT intervention focused on preventing readmissions. Caregiver and study burden but not privacy were major reasons to decline participation. Reducing perceived patient-caregiver burden and improving communication may improve participation. CLINICALTRIAL ClinicalTrials.gov NCT03564626; https://www.clinicaltrials.gov/ct2/show/NCT03564626

[1]  E. Tapper,et al.  Acceptance and use of a smartphone application in cirrhosis , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[2]  P. Kamath,et al.  Psychological Burden of Hepatic Encephalopathy on Patients and Caregivers , 2020, Clinical and translational gastroenterology.

[3]  R. Chung,et al.  Attitudes towards digital health tools for outpatient cirrhosis management in patients with decompensated cirrhosis , 2020, BMJ Innovations.

[4]  S. Castro,et al.  Acceptance of Mobile Health Applications: Examining Key Determinants and Moderators , 2019, Front. Psychol..

[5]  A. Rastogi,et al.  Use of smartphone applications to improve quality of bowel preparation for colonoscopy: a systematic review and meta-analysis , 2019, Endoscopy International Open.

[6]  J. Rehm,et al.  Alcohol use, opioid overdose and socioeconomic status in Canada: A threat to life expectancy? , 2018, Canadian Medical Association Journal.

[7]  A. Sanyal,et al.  The patient buddy app can potentially prevent hepatic encephalopathy‐related readmissions , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[8]  S. Asch,et al.  Trends in 30-Day and 1-Year Mortality Among Patients Hospitalized With Cirrhosis From 2004 to 2013 , 2017, The American Journal of Gastroenterology.

[9]  M. Volk,et al.  Strategies to Reduce 30-Day Readmissions in Patients with Cirrhosis , 2017, Current Gastroenterology Reports.

[10]  E. Tapper,et al.  Rates of and Reasons for Hospital Readmissions in Patients With Cirrhosis: A Multistate Population-based Cohort Study. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[11]  K. Reddy,et al.  The 3‐month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis , 2016, Hepatology.

[12]  M. Mittleman,et al.  A Quality Improvement Initiative Reduces 30-Day Rate of Readmission for Patients With Cirrhosis. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[13]  P. De Cruz,et al.  Mobile Phone Apps for Inflammatory Bowel Disease Self-Management: A Systematic Assessment of Content and Tools , 2016, JMIR mHealth and uHealth.

[14]  J. Bajaj,et al.  Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study , 2016, The American Journal of Gastroenterology.

[15]  A. Sanyal,et al.  Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  Michael L Volk,et al.  Hospital Readmissions Among Patients With Decompensated Cirrhosis , 2012, The American Journal of Gastroenterology.

[17]  A. Sanyal,et al.  The Multi-Dimensional Burden of Cirrhosis and Hepatic Encephalopathy on Patients and Caregivers , 2011, The American Journal of Gastroenterology.